Arthur T. Sands
2013 - Lexicon Pharmaceuticals
In 2013, Arthur T. Sands earned a total compensation of $1.8M as Former President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Option Awards | $891,296 |
|---|---|
| Salary | $580,000 |
| Stock Awards | $292,600 |
| Other | $7,095 |
| Total | $1,770,991 |
Sands received $891.3K in option awards, accounting for 50% of the total pay in 2013.
Sands also received $580K in salary, $292.6K in stock awards and $7.1K in other compensation.
Rankings
In 2013, Arthur T. Sands' compensation ranked 4,302nd out of 12,286 executives tracked by ExecPay. In other words, Sands earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,302 out of 12,286 | 65th |
Division Manufacturing | 1,471 out of 4,612 | 68th |
Major group Chemicals And Allied Products | 411 out of 1,466 | 72nd |
Industry group Drugs | 284 out of 1,160 | 76th |
Industry Pharmaceutical Preparations | 229 out of 890 | 74th |
Source: SEC filing on March 13, 2015.
Sands' colleagues
We found four more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2013.
2013
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2013
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2013
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2013
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, CMC and Supply Operations
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021